Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.71)
# 3,390
Out of 5,140 analysts
205
Total ratings
22.38%
Success rate
-7.29%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.00 | +800.00% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $1.53 | +12,971.90% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.11 | +272.18% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.03 | +288.35% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.13 | -6.10% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.46 | +8,030.08% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.84 | +932.61% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $0.80 | +2,525.00% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.13 | +1,227.43% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.01 | +27,760.70% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $2.22 | +5,305.41% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.16 | +390.20% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.32 | +2,172.73% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $9.20 | +106.52% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.19 | +630.59% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.80 | +654.72% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.71 | +14,004.37% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54,000 | $4.65 | +1,161,190.32% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.30 | +769.57% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.95 | +398,634.18% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $8.55 | +5,747.95% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $34.30 | +599.71% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.79 | +10,013.78% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $12.26 | +65,152.85% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.88 | +272.34% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.85 | +1,521.62% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.27 | +836.77% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.80 | +275.00% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.97 | +68.35% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $67.94 | -64.67% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.54 | +632,062.66% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $0.98 | +1,931,186.85% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.00
Upside: +800.00%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $1.53
Upside: +12,971.90%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.11
Upside: +272.18%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.03
Upside: +288.35%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.13
Upside: -6.10%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.46
Upside: +8,030.08%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $1.84
Upside: +932.61%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $0.80
Upside: +2,525.00%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.13
Upside: +1,227.43%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.01
Upside: +27,760.70%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $2.22
Upside: +5,305.41%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $8.16
Upside: +390.20%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $1.32
Upside: +2,172.73%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $9.20
Upside: +106.52%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.19
Upside: +630.59%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.80
Upside: +654.72%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.71
Upside: +14,004.37%
Nov 12, 2024
Reiterates: Buy
Price Target: $54,000
Current: $4.65
Upside: +1,161,190.32%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.30
Upside: +769.57%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.95
Upside: +398,634.18%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $8.55
Upside: +5,747.95%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $34.30
Upside: +599.71%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.79
Upside: +10,013.78%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $12.26
Upside: +65,152.85%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.88
Upside: +272.34%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.85
Upside: +1,521.62%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.27
Upside: +836.77%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $4.80
Upside: +275.00%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.97
Upside: +68.35%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $67.94
Upside: -64.67%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.54
Upside: +632,062.66%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $0.98
Upside: +1,931,186.85%